BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Parker K, Wong J. Is polypharmacy an increasing burden in chronic kidney disease? The German experience. Clin Kidney J 2019;12:659-62. [PMID: 31584570 DOI: 10.1093/ckj/sfz072] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Campbell JR, Al-Jahdali H, Bah B, Belo M, Cook VJ, Long R, Schwartzman K, Trajman A, Menzies D. Safety and Efficacy of Rifampin or Isoniazid Among People With Mycobacterium tuberculosis Infection and Living With Human Immunodeficiency Virus or Other Health Conditions: Post Hoc Analysis of 2 Randomized Trials. Clin Infect Dis 2021;73:e3545-54. [PMID: 32785709 DOI: 10.1093/cid/ciaa1169] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
2 Owsiany MT, Hawley CE, Paik JM. Differential Diagnoses and Clinical Implications of Medication Nonadherence in Older Patients with Chronic Kidney Disease: A Review. Drugs Aging 2020;37:875-84. [PMID: 33030671 DOI: 10.1007/s40266-020-00804-8] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 van Oosten MJM, Logtenberg SJJ, Hemmelder MH, Leegte MJH, Bilo HJG, Jager KJ, Stel VS. Polypharmacy and medication use in patients with chronic kidney disease with and without kidney replacement therapy compared to matched controls. Clin Kidney J 2021;14:2497-523. [PMID: 34950462 DOI: 10.1093/ckj/sfab120] [Reference Citation Analysis]
4 Papotti B, Marchi C, Adorni MP, Potì F. Drug-drug interactions in polypharmacy patients: The impact of renal impairment. Curr Res Pharmacol Drug Discov 2021;2:100020. [PMID: 34909655 DOI: 10.1016/j.crphar.2021.100020] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Wakasugi M, Yokoseki A, Wada M, Momotsu T, Sato K, Kawashima H, Nakamura K, Onodera O, Narita I. Polypharmacy, chronic kidney disease, and incident fragility fracture: a prospective cohort study. J Bone Miner Metab 2021. [PMID: 34729651 DOI: 10.1007/s00774-021-01272-9] [Reference Citation Analysis]